bioMONTR Labs

bioMONTR Labs is a privately held, revenue-generating diagnostics services company founded in 2020 by industry veterans Daniel and Anita McClernon. The company operates as a contract research organization (CRO)-like lab, offering assay development, clinical trial testing, and specialized molecular diagnostic services primarily for infectious disease targets in nephrology and oncology. Its core competency lies in highly sensitive viral load monitoring and biomarker detection, supported by a track record of scientific publications and presentations. The business model is built on providing flexible, outsourced laboratory services to pharmaceutical and biotech clients.

Expertise in implementing and developing high-sensitivity molecular assays on state-of-the-art platforms, with a focus on ultra-sensitive viral load testing (e.g., HBV pgRNA, low-level HIV RNA) and biomarker quantification for clinical trials and diagnostic support.

Competes with large, global Contract Research Organizations (CROs) offering central lab services (e.g., LabCorp, Q2 Solutions) and smaller, niche specialty laboratories focused on molecular diagnostics. Differentiation is based on deep scientific expertise in ultra-sensitive assay development for specific infectious disease targets and a flexible, client-focused service model.